medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (5)


Hepatitis E virus exposure in pregnant women in rural Durango, Mexico

Alvarado-Esquivel C, Sánchez-Anguiano LF, Hernández-Tinoco J

Idioma: Ingles.
Referencias bibliográficas: 35
Paginas: 510-517
Archivo PDF: 101.18 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mori Y, Matsuura Y. Structure of hepatitis E viral particle. Virus Res 2011; 161: 59-64. doi: 10.1016/ j.virusres.2011.03.015.

  2. Tahan V, Ozdogan O, Tozun N. Epidemiology of viral hepatitis in the Mediterranean basin. Rocz Akad Med Bialymst 2003; 48: 11-7.

  3. Coton T, Delpy R, Hance P, Carré D, Guisset M. Autochthonous hepatitis E virus in Southeastern France. 2 cases. Presse Med 2005; 34: 651-4.

  4. Shrestha SM. Hepatitis E in Nepal. Kathmandu Univ Med J (KUMJ) 2006;4:530-44.

  5. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709. doi: 10.1016/S1473-3099(08)70255-X.

  6. Wedemeyer H, Rybczynska J, Pischke S, Krawczynski K. Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis 2013; 33: 71-8. doi: 10.1055/s-0033-1338118.

  7. Dilawari JB, Singh K, Chawla YK, Ramesh GN, Chauhan A, Bhusnurmath SR, Sharma TR, et al. Hepatitis E virus: epidemiological, clinical and serological studies of north Indian epidemic. Indian J Gastroenterol 1994; 13: 44-8.

  8. Singh S, Mohanty A, Joshi YK, Dwivedi SN, Deka D. Outcome of hepatitis E virus infection in Indian pregnant women admitted to a tertiary care hospital. Indian J Med Res 2001; 113: 35-9.

  9. Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol 2008; 80: 1747-8. doi: 10.1002/jmv.21284.

  10. Riveiro-Barciela M, Rodríguez-Frías F, Buti M. Hepatitis E virus: new faces of an old infection. Ann Hepatol 2013; 12: 861-70.

  11. Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012; 11: 618-22.

  12. Christou L, Kosmidou M. Hepatitis E virus in the Western world-a pork-related zoonosis. Clin Microbiol Infect 2013; 19: 600-4. doi: 10.1111/1469-0691.12214.

  13. Balayan MS. Epidemiology of hepatitis E virus infection. J Viral Hepat 1997; 4: 155-65.

  14. Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, García-López CR, Estrada-Martínez S, Sifuentes-Álvarez A, Marsal-Hernández JF, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol 2009; 95: 271-4. doi: 10.1645/ GE-1829.1.

  15. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G. La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med 1988; 19: 351-60.

  16. Rayis DA, Jumaa AM, Gasim GI, Karsany MS, Adam I. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health 2013; 107: 66- 8. doi: 10.1179/2047773213Y.0000000076.

  17. Yun H, Lee HJ, Cheon D, Chu C, Oh KW, Kim YT, Jee Y. Seroprevalence of hepatitis a and e viruses based on the third Korea national health and nutrition survey in Korea. Osong Public Health Res Perspect 2011; 2: 46-50. doi: 10.1016/j.phrp.2011.04.009.

  18. Alvarez-Muñoz MT, Torres J, Damasio L, Gómez A, Tapia- Conyer R, Muñoz O. Seroepidemiology of hepatitis E virus infection in Mexican subjects 1 to 29 years of age. Arch Med Res 1999; 30: 251-4.

  19. Bernal R R, Licona SJE. Seroepidemiology of hepatitis E in the State of Hidalgo. Rev Gastroenterol Mex 1996; 61: 233-8.

  20. Redlinger T, O’Rourke K, Nickey L, Martinez G. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Tex Med 1998; 94: 68-71.

  21. Pujol FH, Favorov MO, Marcano T, Esté JA, Magris M, Liprandi F, et al. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol 1994; 42: 234-6.

  22. Trinta KS, Liberto MI, de Paula VS, Yoshida CF, Gaspar AM. Hepatitis E virus infection in selected Brazilian populations. Mem Inst Oswaldo Cruz 2001; 96: 25-9.

  23. Begum N, Devi SG, Husain SA, Ashok Kumar, Kar P. Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study. Indian J Med Res 2009; 130: 709-13.

  24. Traoré KA, Rouamba H, Nébié Y, Sanou M, Traoré AS, Barro N, Roques P. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS One 2012; 7: e48125. doi: 10.1371/journal.pone.0048125.

  25. El-Tras WF, Tayel AA, El-Kady NN. Seroprevalence of hepatitis E virus in humans and geographically matched food animals in Egypt. Zoonoses Public Health 2013; 60: 244-51. doi:10.1111/j.1863-2378.2012.01516.x.

  26. Caron M, Kazanji M. Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 2008; 5: 158. doi: 10.1186/1743-422X-5-158.

  27. Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, et al. Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia. Pathol Biol (Paris) 2011; 59: e115-8. doi: 10.1016/j.patbio.2009.06.004.

  28. Caron M, Bouscaillou J, Kazanji M. Acute risk for hepatitis E virus infection among HIV-1-positive pregnant women in central Africa. Virol J 2012; 9: 254. doi: 10.1186/1743- 422X-9-254.

  29. Lindemann ML, Gabilondo G, Romero B, de la Maza OM, Pérez-Gracia MT. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol 2010; 82: 1666-8. doi: 10.1002/ jmv.21840.

  30. Ibarra H, Riedemann S, Reinhardt G, Frieck P, Siegel F, Toledo C, Calvo M, et al. Prevalence of hepatitis E virus antibodies in blood donors and other population groups in southern Chile. Rev Med Chil 1997; 125: 275-8.

  31. Zhang W, Shen Q, Mou J, Gong G, Yang Z, Cui L, et al. Hepatitis E virus infection among domestic animals in eastern China. Zoonoses Public Health 2008; 55: 291-8. doi: 10.1111/j.1863-2378.2008.01136.x.

  32. Geng Y, Wang C, Zhao C, Yu X, Harrison TJ, Tian K, Wang Y. Serological prevalence of hepatitis E virus in domestic animals and diversity of genotype 4 hepatitis E virus in China. Vector Borne Zoonotic Dis 2010; 10: 765-70. doi: 10.1089/vbz.2009.0168.

  33. Geng J, Wang L, Wang X, Fu H, Bu Q, Liu P, et al. Potential risk of zoonotic transmission from young swine to human: seroepidemiological and genetic characterization of hepatitis E virus in human and various animals in Beijing, China. J Viral Hepat 2011; 18:e583-90. doi: 10.1111/ j.1365-2893.2011.01472.x.

  34. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799-805. doi: 10.1002/ jmv.21656.

  35. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207: 497-500. doi: 10.1093/ infdis/jis688.




2020     |     www.medigraphic.com